Guanze Medical Information Industry (Holding) Co (HKSE:02427) Other Stockholders Equity: HK$56.99 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02427 Guanze Medical Information Industry (Holding) Co Ltd HKSE:02427
52 GF Score
Price HK$2.29
GF Value HK$0.28
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Guanze Medical Information Industry (Holding) Co Other Stockholders Equity?

Guanze Medical Information Industry (Holding) Co HKSE:02427 52 Other Stockholders Equity is HK$56.99 Mil as of Dec. 2025. GuruFocus rates HKSE:02427 with a GF Score™ of 52/100 and a GF Value™ of HK$0.28 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Guanze Medical Information Industry (Holding) Co's Other Stockholders Equity for the quarter that ended in Dec. 2025 was HK$56.99 Mil.

Guanze Medical Information Industry (Holding) Co's quarterly Other Stockholders Equity increased from Dec. 2024 (HK$53.23 Mil) to Jun. 2025 (HK$55.17 Mil) and increased from Jun. 2025 (HK$55.17 Mil) to Dec. 2025 (HK$56.99 Mil).

Guanze Medical Information Industry (Holding) Co's annual Other Stockholders Equity declined from Dec. 2023 (HK$64.45 Mil) to Dec. 2024 (HK$53.23 Mil) but then increased from Dec. 2024 (HK$53.23 Mil) to Dec. 2025 (HK$56.99 Mil).

Guanze Medical Information Industry (Holding) Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Guanze Medical Information Industry (Holding) Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guanze Medical Information Industry (Holding) Co Other Stockholders Equity Chart

Guanze Medical Information Industry (Holding) Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 74.99 63.29 64.45 53.23 56.99

Guanze Medical Information Industry (Holding) Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64.45 52.16 53.23 55.17 56.99
HKSE:02427
52GF Score
Guanze Medical Information Industry (Holding) Co Ltd HKSE:02427
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guanze Medical Information Industry (Holding) Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of HK$56.99 Mil mean?
Guanze Medical Information Industry (Holding) Co (HKSE:02427) has a Other Stockholders Equity of HK$56.99 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors.
Is Guanze Medical Information Industry (Holding) Co's Other Stockholders Equity too high?
Guanze Medical Information Industry (Holding) Co's current Other Stockholders Equity is HK$56.99 Mil. Overall, Guanze Medical Information Industry (Holding) Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guanze Medical Information Industry (Holding) Co's Other Stockholders Equity compare to TMO and DHR?
Guanze Medical Information Industry (Holding) Co's Other Stockholders Equity of HK$56.99 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors. Guanze Medical Information Industry (Holding) Co's current Other Stockholders Equity is HK$56.99 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guanze Medical Information Industry (Holding) Co stock overvalued right now?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co (HKSE:02427) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.28, compared to a current price of HK$2.29 — trading 716.1% above its estimated fair value. The current Other Stockholders Equity is HK$56.99 Mil. Guanze Medical Information Industry (Holding) Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Guanze Medical Information Industry (Holding) Co (HKSE:02427), the current Other Stockholders Equity is HK$56.99 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guanze Medical Information Industry (Holding) Co (HKSE:02427) Overvalued in 2026?

Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co stock appears to be overvalued. The current stock price of HK$2.29 is trading 716.1% above its estimated GF Value™ of HK$0.28. GuruFocus considers Guanze Medical Information Industry (Holding) Co to be Significantly Overvalued.

Key valuation signals for HKSE:02427:

  • Other Stockholders Equity: HK$56.99 Mil
  • GF Value™: HK$0.28 vs. price of HK$2.29 (716.1% above fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the HKSE:02427 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guanze Medical Information Industry (Holding) Co Business Description

Address No. 2966 Chunhui Road, Room 501-A, Block 10 Strategic Emerging Industry Base, Jinan High-tech Zone, Shandong Province, Jinan, CHN
Guanze Medical Information Industry (Holding) Co Ltd is a medical imaging solutions provider, principally engaged in providing medical imaging film products and medical imaging cloud services in Shandong Province. The company generates the majority of its revenue from the PRC.
52GF Score

Get the complete analysis for HKSE:02427

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.29
Price
HK$0.28
GF Value